Royal Perth Hospital - Cell and Tissue Therapies WA (CTTWA)

Site

Cell & Tissue Therapies WA (CTTWA)

Accreditation No.

19786

Site No.

23076

Date of Accreditation

22 Oct 2015

Address

Level 2 North Block, Wellington Street
Perth, WA 6000
Australia

rph.health.wa.gov.au

Contact

Dr Zlatibor Velickovic P: +61 (08) 92241987

Availability

Services not available to external clients

Supervision

HPS (Haemopoietic processing, storage)

Scope of Accreditation

Print scopes
Cell & Tissue Therapies WA (CTTWA)

ISO 15189 (2012)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Haematology - Full blood examination Blood Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean corpuscular haemoglobin (MCH); Mean corpuscular haemoglobin concentration (MCHC); Mean platelet volume (MPV); Platelet count; Red blood cell distribution width (RDW)
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) Blood; Bone marrow CD16; CD19; CD3; CD34; CD4; CD45; CD56; CD8; Total leucocyte number; Total lymphocyte number; Viable cell count
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProducts received from AN 19801 SN 23095 and AN 19786 SN 23076 Bone marrow; Cord blood; Haemopoietic progenitor cells Processing; Storage (includes freezing/thawing)

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.